CA
NZ
UK
AU
IND
US
ServiceTitan, Inc. (Nasdaq: TTAN) surged 16.96% in pre-market trading on June 5th, 2026, advancing from $74.33 to $86.94, after reporting fiscal Q1 2027 results exceeding consensus estimates and raising full-year financial guidance. Revenue of $268.8 million beat analyst estimates by approximately $12 million, representing …
Shares of Solidion Technology Inc. (Nasdaq: STI) closed at $22.71 on June 4, 2026, up 350.60% from a prior close of $5.04, with the session range spanning $18.87 to $38.15. In pre-market trading on June 5, the stock added a further 82.74% to $41.50 …
WTI at $92.34 down 0.75% and Brent at $94.60 down 0.45% Friday, but WTI was on track for its first weekly gain in three weeks, up more than 6%. Hezbollah rejected the U.S.-brokered ceasefire proposal and said it would not withdraw troops from Lebanon, …
The June 4, 2026, session triggered a definitive regime shift in macro trend leadership. Driven by a +3.07% surge, Health Care (XLV) crossed into the Leading quadrant, joining Technology (XLK) to forge a unique Defensive-Growth Barbell. While tech absorbed a -1.56% absolute flush, it …
The US equity market session on June 4, 2026, delivered a high-conviction, zero-sum rotational flush that completely dismantled recent mega-cap growth concentration. The absolute performance matrix reveals a disciplined, massiveCapitalreallocation script. Programmatic systems treated the overextended technology complex (XLK) as an open ATM, extracting …
Amazon closed at $253.79, gaining $3.77 (+1.51%) in a constructive session reflecting continued buying interest near recent consolidation lows. Price traded between $251.75 and $255.83 intraday, reflecting orderly price action consistent with a stock finding support after a meaningful pullback from highs. The stock …
Eli Lilly has emerged as one of the most influential pharmaceutical companies in the world, driven by itsLeadershipin obesity, diabetes, neuroscience, and immunology. The company's breakthrough therapies have transformed treatment standards while creating one of the strongest growth profiles in the healthcare sector.
Travere Therapeutics has emerged as one of the most compelling growth stories in the biotechnology sector as the company successfully transitions from a development-stage biotech into a commercial rare-diseaseFranchise. Investor confidence has strengthened considerably following the expansion of FILSPARI's commercial opportunity, creating a pathway …
Tradr 2X Long Upstart ETF (NASDAQ: UPSX) climbed 12.10% today, reflecting a leveraged response to renewed investor interest in Upstart Holdings (NASDAQ: UPST). The ETF is designed to magnify daily movements in Upstart Holdings (NASDAQ: UPST), making its performance more sensitive to shifts in …
GraniteShares 2x Long Reddit ETF (NASDAQ: RDTL) is climbing as Reddit (NYSE: RDDT), its underlying exposure, gains from improving investor sentiment around advertising growth and user monetisation.
Please wait processing your request...